Ingevity NGVT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 39.3%+1.5pp | 39.3%+5.0pp | 40%+3.6pp | 39.8%+7.1pp | 37.8%+5.1pp | |
| Net margin | -10.6%+19.4pp | -13.9%+19.7pp | -6.8%+46.1pp | -19.3%+17.4pp | -30%-21.1pp | |
| Returns | ||||||
| Return on equity | -93.5%-1.2pp | -148.6%-40.5pp | -46.8%+74.0pp | -115%-28.7pp | -92.3%-74.9pp | |
| Return on invested capital | -5%— | -4.6%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.1× | 0.7×+0.1× | 0.6×+0.2× | 0.6×+0.1× | 0.5×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.4×-0.6× | 1.3×-0.5× | 1.3×-0.5× | 1.4×-0.6× | 2×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 35.1×+28.7× | 46.8×+38.5× | 10.1×+2.4× | 12.2×+6.3× | 6.4×+3.5× | |
| Net debt / EBITDA | 42×— | 36×— | —— | —— | —— | |
| Valuation | ||||||
| Market capitalization | $2.51B+73.9% | $2.13B+43.7% | $2.01B+42.0% | $1.53B-3.5% | $1.44B-16.5% | |
| Price / sales | 2.1×+0.9× | 1.8×+0.7× | 1.7×+0.3× | 1.3×-0.1× | 1.2×-0.2× | |
| Price / book | 64.5×+58.3× | 71.7×+64.1× | 14.6×+8.0× | 12.7×+7.1× | 6.1×+3.1× | |
| EV / EBITDA | 124.8×— | 94.5×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Ingevity's ratios come from?
- Every ratio is computed from Ingevity's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
